Biohealth Innovation
Dr. Dipanjan Pan and Phil Robilotto of the University of Maryland, Baltimore, join BioTalk to discuss RNA Disease Diagnostics, UM Ventures, and the commercialization of new medical technologies
Listen via Apple http://apple.co/3bsUsda, Google http://bit.ly/38l26Vd , Spotify http://spoti.fi/38kp9zu, and TuneIN http://bit.ly/2MVFqDp.
The 6-year-old company will merge with a blank-check firm to go public.
The federal lab system is an enormous $50 billion-plus enterprise of internal research and development taking place in federal facilities across the United States. As other governments around the world, including China, pour billions of dollars into government labs and research parks focused on advanced technologies, it is imperative that we use all aspects of country’s own innovation ecosystem in the most creative ways possible, including our federal labs.
GSK Biologicals and its affiliate GSK Vaccines Institute for Global Health (GVGH) are currently working on two vaccine projects. The first is to prevent Group A Streptococcus infections, commonly known as Strep Throat, which is a major reason for antibiotic prescriptions and cause of immune-mediated diseases.
The second project GSK is working is a vaccine to prevent infections caused by Salmonella enterica, which cause Invasive nontyphoidal salmonellosis (iNTS) disease and typhoid fever, major causes of death among children and significant health challenges primarily in sub-Saharan African countries.
Despite recent challenges, venture capital firms are still seeking out investment opportunities across the country. Since our last analysis of most active VCs in October 2020, we've seen shake-ups across 9 states. Our graphic maps out the most active VC investor in every US state.
Although startups based in California, New York, and Massachusetts have traditionally accounted for the majority of VC tech investment in the US, VCs are spurring other hotbeds of innovation across the country.
Image: https://www.cbinsights.com
The National Institutes of Health funds what it calls extramural research in a wide variety of fields. Our guest has for many years worked to ensure that small enterprises got their share of the grants. Now she’s the recipient of a Tibbets Award from the Small Business Administration for advancing the Small Business Technology Transfer and Small Business Innovation Research programs. For more, the director of the Office of Clinical Policy and Programs at the FDA., Dr. Jodi Black, joined Federal Drive with Tom Temin.
Image: https://en.wikipedia.org/wiki/Jodi_Black#/media/File:Jodi_Black.jpg
BioHealth Capital Fund - AlphaMaven Video PitchBook
They are joining a program that plans to expand in the D.C. region with a new leader.
Image: Melinda Gates' incubation and investment firm, Pivotal Ventures, is funding a new initiative at the University of Maryland and George Mason University to draw more women to their tech degree programs. THE NEW YORK TIMES/KYLE JOHNSON
As the U.S. makes headway in its coronavirus vaccination campaign, Emergent BioSolutions CEO Bob Kramer appeared on CNBC Wednesday to explain his company’s role in manufacturing doses.
The Gaithersburg, Maryland-based contractor last year landed a multi-year deal to be the domestic producer of the Covid-19 vaccine from Johnson & Johnson, whose single-dose shot was cleared for use in the U.S. over the weekend. It also has a multi-year contract production contract for a vaccine developed by a British-Swedish biopharmaceutical company, AstraZeneca.
Image: https://www.cnbc.com/ - From Video
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has launched its QIAsphere cloud-based platform that will allow labs and QIAstat-Dx users to monitor tests and instrument status remotely 24 hours a day, 7 days a week.
QIAsphere sets new standards for syndromic testing digital health, providing users with remote visibility of their testing routine. It can monitor a nearly unlimited number of instruments, providing visibility of testing routine across different hospitals or satellite labs. The continuous connectivity to QIAGEN service reduces systems downtime and enabling fast and accurate syndromic testing. Digital diagnostics and remote analytics will be crucial to bring syndromic testing closer to patients in the coming years.
Washington, D.C.-based Children's National Hospital, Virginia Tech and Johnson & Johnson Innovation have partnered to launch a new healthcare technology and research innovation campus, according to a March 1 news release.
The Children's National Research & Innovation Campus will feature research into new pediatric medical treatments and technologies as well as a life sciences incubator for about 50 startups across the pharmaceutical, medical device, consumer and health tech sectors.
SARS-CoV-2 vaccinations are accelerating across the U.S. with approximately 66 million first doses having been administered as of February 25th, representing 13.6% of the country, according to NPR. The vaccination effort received another boost with the Food and Drug Administration’s recent Emergency Use Authorization (EUA) of Johnson & Johnson’s (J&J) single-dose vaccine.
Image: https://biobuzz.io
The 12-year-old George Mason University spinout has taken over 12,000 more square feet, not far from its headquarters.
Image: Ross Dunlap is co-founder and CEO of Ceres Nanosciences. COURTESY ROSS DUNLAP
Montgomery College and the Universities at Shady Grove (USG), in conjunction with the University of Maryland, Baltimore County (UMBC), have completed two intensive pilot training programs designed to create a skilled talent pipeline to support the life sciences sector in Montgomery County. The four-week “Bio Boot Camp” program—a public-private effort announced in November 2020—was created to help kickstart recovery from the COVID-19 health crisis.
Image: https://montgomerycomd.blogspot.com
The entrepreneurs behind an exited Baltimore biotech company are creating a new center for immigration law in the city.
A $5 million gift from Marco and Debbie Chacón to the University of Maryland Francis King Carey School of Law will help to establish the Baltimore-based school’s new Chacón Center for Immigrant Justice.
The couple founded Paragon Bioservices, the contract manufacturing and development company that was acquired by Catalent in 2019 for $1.2 billion. Marco Chacón served as CEO and Debbie Chacón served as VP when the company moved to the University of Maryland BioPark in 2009. Now known as Paragon Gene Therapy, it still has a base at the BioPark, and Marco Chacón founded Irazú Bio, which is also based in the BioPark.
Image: Marco and Debbie Chacón founded Paragon Bioservices. (Photo courtesy of University of Maryland School of Law)
All eyes are on the global rollout of COVID-19 vaccines. Achieving the broad uptake needed to reach population immunity and curb the virus’s spread will require an unprecedented effort among health workers, scientists and stakeholders at every step of the supply chain.
During this 90 min event, experts from organizations central to vaccine development and delivery, regulatory oversight and quality assurance will discuss over the course of two high-level panels what’s needed for the global COVID-19 vaccination campaign, how to build public trust in the quality and effectiveness of vaccines, and how these investments can build better systems for the future.
BALTIMORE (WJZ) — As students and staff return to the classroom, state leaders are working to get every teacher vaccinated. Now, there’s a way to track the progress.
Johns Hopkins University is launching its teacher vaccination tracker.
Image: https://baltimore.cbslocal.com - From Video
COLUMBIA, Md. (March 8, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $400,000 in two technology start-ups. TEDCO’s Seed Fund invests in early-stage, technology and life sciences companies and includes gap financing.
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
Shares of Altimmune Inc. ALT were down 4.8% in trading on Thursday after the company said it started enrolling participants in a Phase 1 clinical trial for its COVID-19 vaccine candidate. Altimmune is developing a single-dose nasal spray vaccine. The study is expected to enroll up to 180 healthy adults between the ages of 18 and 55 years old, who will receive one of three doses of the experimental vaccine. The company said it expects to share the first batch of clinical data from this trial in the second quarter of this year. Altimmune's stock has soared 969.9% over the past 12 months, while the broader S&P 500 SPX is up 21.7%.
Are you a BioHealth entrepreneur working with an academic institution on your oncology R&D? The NCI SBIR Development Center has announced a new funding opportunity to support academic post-doc transitions to industry. This new and unique Fast-Track only award structure comprises a Phase I STTR that transitions to a Phase II SBIR. An STTR award is a collaborative award made to small businesses working closely with a university deadline to apply by 3/25. For more information, check online: Small Business Transition Grant | NCI: SBIR & STTR (cancer.gov)
Image: https://sbir.cancer.gov/funding/sbtg From Video
Emergent BioSolutions’ contract development and manufacturing (CDMO) business is playing a crucial role in supporting the battle against COVID-19. The company has contracted with multiple vaccine makers, including AstraZeneca and Johnson & Johnson, to manufacture the preventative medications.
It’s a critical role not taken lightly by the employees in the company’s two Baltimore-based facilities. Sean Kirk, executive vice president of Manufacturing and Technical Operations at Emergent, said the importance of the work taken on by Emergent, as well as the biopharma industry at large to battle the pandemic is not lost on him.
Alexandria Venture Investments Senior Associate, Conley Jones, virtually sits down with Rich Bendis on BioTalk to discuss Venture Trends, Investment Goals, and their National Footprint
Listen now on Apple http://apple.co/3sCbtaH, Google http://bit.ly/3kG3MgX, Spotify http://spoti.fi/3kKNGmt, and TuneIn http://bit.ly/3uGvJtJ.
George Mason University President Gregory Washington on Monday announced he has formed an advisory roundtable of nearly 30 regional business executives and community leaders to focus on the university’s innovation initiative.
The President’s Innovation Advisory Council will focus on issues such as GMU’s efforts to increase the pipeline of tech workers. George Mason’s innovation initiative includes $235 million in General Assembly funding to produce approximately 30% of the 25,000 undergraduate and graduate majors as part of the state’s Tech Talent Investment Program.
Image: Concept rendering of George Mason University's Institute for Digital InnovAtion (IDIA) in Arlington
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
SoPE + GW Startup Pitch Application Apply now to pitch at our March 24th Event: Pitch Perfect II: In Action!
Application is limited to SoPE members or those affiliated with George Washington University (students, staff, licensees, etc). Limited spots available. Submission does not guarantee acceptance.
Submission deadline: March 5th, 2021.
ROCKVILLE, Md.--(BUSINESS WIRE)--Feb. 23, 2021-- GlycoMimetics, Inc. (Nasdaq: GLYC) today announced the promotion of Eric Feldman, M.D., to Senior Vice President and Chief Medical Officer. Dr. Feldman joined the Company in 2019 and was previously Vice President, Global Clinical Development.
“Eric is internationally recognized for his work in the development of new therapies for the treatment of leukemias and related bone marrow disorders, and in the past two years, has established himself as a leader in our management group as well as in the trenches with our clinical operations team. Having spent his career dedicated to patients with hematologic malignancies, he is especially well positioned to lead our uproleselan program as it advances through Phase 3 clinical trials. In addition, his extensive clinical research background will serve us well as we drive forward other programs in our pipeline,” said Rachel King, Chief Executive Officer.
This free webinar will feature a fireside chat-style conversation with Dr. Robert Scharpf (Delfi Diagnostics) and Dr. Christie Bergerson (Exponent). Drs. Scharpf and Bergerson will discuss how machine learning and artificial intelligence are impacting biomedical engineering and the wider world of human health.
Rich Bendis (BioHealth Innovation/BioTalk podcast) will facilitate the discussion. View the speaker bios for more information.
After the main session, participants will have the opportunity to join one of three, smaller breakout sessions:
COLUMBIA, Md. (February 24, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today the appointment of Jack Miner as the chief investment officer. He begins his tenure with TEDCO on March 1, 2021.
“Jack brings many years of venture capital and leadership experience to fill this critical role at TEDCO,” said Troy LeMaile-Stovall, TEDCO’s CEO and executive director. “Leveraging his extensive knowledge of the entrepreneurial and venture capital community, we’re looking forward to the impact he will make in fostering TEDCO’s mission to better serve our entrepreneurs.”
Many policy decisions on the pandemic -- in Washington and locally -- are driven by an online data tool developed at Johns Hopkins University. Correspondent David Begnaud spoke to one of the people behind the site.
Image: https://www.kctv5.com - From Video
PLYMOUTH MEETING, Pa. and GERMANTOWN, Md. and HILDEN, Germany, Feb. 24, 2021 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO's therapies. (*Complementary when referring to the US regulatory pathway.)
Richmond-based pharmaceutical development company Phlow Corp. has formed a partnership with a nonprofit organization that will involve opening new laboratory operations in downtown Richmond.
Phlow, which is working to build the supply of medicines that face shortages in the U.S. market, said Monday that it has formed a strategic alliance with United States Pharmacopeia to develop a new laboratory operation in the Virginia Bio+Tech Research Park.
Image: Daniel Sangjib Min - Times-Dispatch
The Defense Advanced Research Projects Agency will now allow small businesses that are majority owned by private equity firms to bid on both Small Business Innovation Research and Small Business Technology Transfer opportunities.
Congratulations to the BHI Board-members who made the list.
Biographer Robert Caro, in discussing his craft, wrote that “power reveals.” It reveals the true character of people, the nature of their endeavors, their goals and ambitions.
Welcome to The Daily Record’s inaugural Power 100 List.
We are recognizing the men and women across Maryland who are shaping our businesses, governments, nonprofits, law firms and other critical institutions. In essence, they are playing an outsize role in the culture, lifestyle, civic conversation and economic fortunes of Maryland.